Cerebral glucose metabolism in patients with AD and different APOE genotypes

Cerebral fluorodeoxyglucose PET imaging was performed in all patients by a standardized protocol

A. Drzezga; M. Riemenschneider; B. Strassner; T. Grimmer; M. Peller; A. Knoll; S. Wagenpfeil; S. Minoshima; M. Schwaiger; A. Kurz

2011

Scholarcy highlights

  • Cerebralfluorodeoxyglucose PET imaging was performed in all patients by a standardized protocol
  • A generally similar pattern of cerebral hypometabolism was detected in APOE ε4-positive and -negative patients with Alzheimer disease
  • If you are uploading a letter concerning an article: You must have updated your disclosures within six months: http://submit.neurology.org
  • Read any comments already posted on the article prior to submission
  • I, the first and corresponding author, verify that I have read the contents of the PUBLISHING AGREEMENT form. *
  • NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted

Need more features? Save interactive summary cards to your Scholarcy Library.